News
Relief Mental Health is pleased to announce the addition of Michael Henderson, MSN, APNP, PMHNP-BC, to its West Allis clinic.
With little evidence or regulatory oversight, some mushroom products claim to improve cognitive function while posing a risk ...
Imagine you purchase a bag of gummies labeled nootropic - a term used to describe substances that claim to enhance mental ability and function , or ...
Non-hallucinogenic neuroplastogens offer benefits over classical psychedelics, including simpler delivery, stronger IP protection, and patient tolerability, writes Enveric Biosciences CEO Joseph ...
NEW YORK and AMSTERDAM, Aug. 14, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective ...
Voting is now open for panels to be part of next year’s South by Southwest (SXSW) festival, allowing anyone with an opinion ...
Vail Health’s Behavioral Health Innovation Center director testifies before Congress on psychedelics
Dr. Charles Raison, executive director of Vail Health’s Behavioral Health Innovation Center, spoke to the U.S. House of Representatives’ bipartisan Addiction, Treatment and Recovery Caucus in ...
Maryland’s psychedelics task force has come out with an initial report as it gathers information about various regulatory and ...
Discover six of the top psychedelic companies developing novel drugs to expand the treatment scope for mental health ...
From cellular repair to cognitive resilience, researchers are exploring how psychedelics could influence the biology of aging ...
From the COLlive inbox: "The first time I took psilocybin mushrooms, I thought I was opening a door to the truth. I didn’t realize I might not be able to close it." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results